AVITA Medical Inc. (RCEL)
NASDAQ: RCEL
· Real-Time Price · USD
5.73
-0.07 (-1.21%)
At close: Aug 15, 2025, 12:14 PM
AVITA Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 74.88M | 71.66M | 64.25M | 60.04M | 61.72M | 64.17M | 63.62M | 58.88M | 51.87M | 46.29M | 45.82M | 45.91M | 38.71M | 36.94M | 38.41M | 35.48M | 35.53M | 30.84M |
Cost of Revenue | 11.77M | 10.41M | 9.09M | 8.61M | 8.71M | 9.91M | 10.89M | 11.07M | 10.17M | 8.87M | 8.75M | 7.9M | 6.6M | 6.64M | 7.09M | 7.03M | 7.24M | 6.45M |
Gross Profit | 63.11M | 61.25M | 55.16M | 51.43M | 53.01M | 54.27M | 57.96M | 57.47M | 51.36M | 47.09M | 41.5M | 38.01M | 32.12M | 30.3M | 31.32M | 28.45M | 28.29M | 24.39M |
Operating Income | -46.74M | -51.21M | -56.59M | -58.91M | -59.45M | -60.58M | -58.2M | -54.61M | -49.25M | -41.7M | -39.56M | -42.48M | -39.45M | -34.94M | -30.15M | -25.84M | -34.16M | -48.33M |
Interest Income | n/a | n/a | n/a | n/a | 15.56K | 26.07K | 32.05K | 40.86K | 34.69K | 29.97K | 36.44K | 38.64K | 29.26K | 23.46K | 14.96K | 7.84K | 17.62K | 29.21K |
Pretax Income | -51.57M | -57.01M | -61.79M | -57.27M | -54.58M | -54.79M | -49.91M | -50.68M | -45.88M | -39.37M | -38.26M | -42.08M | -39.29M | -34.94M | -30.18M | -25.84M | -34.17M | -48.16M |
Net Income | -51.57M | -57.05M | -61.84M | -57.32M | -54.67M | -54.87M | -50M | -50.8M | -45.98M | -39.46M | -38.31M | -42.12M | -39.33M | -34.98M | -30.23M | -25.88M | -34.21M | -48.21M |
Selling & General & Admin | 88.17M | 91.01M | 91.39M | 88.12M | 89.17M | 81.3M | 74.53M | 73.7M | 64.2M | 58.85M | 56.17M | 53.57M | 46.15M | 44.98M | 41.69M | 33.97M | 36.48M | 40.84M |
Research & Development | 21.68M | 21.45M | 20.36M | 22.27M | 23.68M | 26.42M | 28.08M | 26.28M | 25.38M | 22.19M | 20.17M | 20.99M | 18.43M | 17.98M | 18.55M | 17.13M | 18.46M | 18.16M |
Other Expenses | n/a | n/a | n/a | -59K | -59K | -59K | -59K | n/a | n/a | n/a | n/a | n/a | 16K | 18K | 18K | 18K | 2K | n/a |
Operating Expenses | 109.85M | 112.46M | 111.75M | 110.34M | 111.64M | 112.83M | 113.06M | 108.11M | 97.2M | 86.42M | 79.72M | 80.05M | 71.38M | 65.22M | 61.48M | 54.28M | 62.43M | 72.52M |
Interest Expense | 5.14M | 5.24M | 5.36M | 5.18M | 3.83M | 2.48M | 1.12M | n/a | n/a | n/a | n/a | n/a | 9K | 18K | 18K | 18K | 9K | n/a |
Selling & Marketing Expenses | 58.4M | 60.39M | 58.2M | 54.3M | 55.54M | 49.03M | 42.93M | 42.03M | 34.11M | 29.65M | 27.94M | 25.44M | 20.5M | 19.31M | 18.13M | 14.91M | 14.66M | 14.77M |
Cost & Expenses | 121.62M | 122.88M | 120.84M | 118.95M | 120.34M | 122.73M | 123.94M | 119.18M | 107.37M | 95.29M | 88.48M | 87.95M | 77.98M | 71.86M | 68.57M | 61.31M | 69.67M | 78.98M |
Income Tax Expense | 3K | 32K | 54K | 47K | 92.11K | 78.63K | 93.5K | 116.76K | 105.9K | 92.17K | 52.65K | 43.54K | 43.29K | 44.49K | 52.31K | 40.43K | 48.4K | 47.2K |
Shares Outstanding (Basic) | 26.37M | 26.25M | 26.15M | 25.98M | 25.76M | 25.64M | 25.48M | 25.4M | 25.24M | 25.2M | 25.08M | 25.01M | 24.97M | 24.94M | 24.93M | 24.91M | 24.86M | 22.73M |
Shares Outstanding (Diluted) | 26.37M | 26.25M | 26.15M | 25.98M | 25.76M | 25.64M | 25.48M | 25.4M | 25.24M | 25.2M | 25.08M | 25.01M | 24.97M | 24.94M | 24.93M | 24.91M | 24.86M | 22.73M |
EPS (Basic) | -1.97 | -2.19 | -2.39 | -2.23 | -2.14 | -2.16 | -1.98 | -2.01 | -1.83 | -1.57 | -1.53 | -1.69 | -1.58 | -1.41 | -1.25 | -1.12 | -1.54 | -2.23 |
EPS (Diluted) | -1.97 | -2.19 | -2.39 | -2.23 | -2.14 | -2.16 | -1.98 | -2.01 | -1.83 | -1.57 | -1.53 | -1.69 | -1.58 | -1.41 | -1.25 | -1.12 | -1.55 | -2.24 |
EBITDA | -44.63M | -50.33M | -55.3M | -50.88M | -50.41M | -53.14M | -50.69M | -53.74M | -48.42M | -40.9M | -38.73M | -41.64M | -38.8M | -34.48M | -29.69M | -25.4M | -33.43M | -47.3M |
EBIT | -46.43M | -51.78M | -56.43M | -52.09M | -51.56M | -54.31M | -37.03M | -31.1M | -16.76M | -9.21M | -9.21M | -9.21M | -9.21M | n/a | -7.89M | -15.19M | -29.46M | -48.33M |
Depreciation & Amortization | 1.79M | 1.44M | 1.13M | 904K | 758K | 700K | 1.36M | 1.89M | 2.03M | 2.13M | 1.3M | 604K | 470K | 399K | 538K | 678K | 715K | 661K |